TAKEDA PHARMACEUTICAL COMPANY LIMITED 1 Revised: October 2009 (12th version) Standard Commodity Classification No
of Japan 873969 - Improving agent for postprandial hyperglycemia – BASEN® Tablets 0
2 BASEN® Tablets 0
3 Prescription drug Caution - Use only pursuant to the prescription of a physician etc
CONTRAINDICATIONS (BASEN® Tablets are contra-indicated in the following patients
) (1) Patients with severe ketosis, or in a state of diabetic coma or pre-coma [Since it becomes essential to quickly rectify hyperglycemia with administration of intrave-nous fluid or insulin, the use of BASEN ® Tablets is not suitable
] (2) Patients with severe infections, before or after operation, or with serious trauma [It is desirable to control plasma glucose with the injection of insulin
Therefore, ad
